Search Within

Ashley Regazzi

Formats
  1. Meeting Abstract (59)
  2. Journal Article (34)
Groups
  1. Department of Medicine (93)
  2. Genitourinary Oncology Service (93)
  3. Solid Tumor Oncology Division (93)
  4. Epidemiology and Biostatistics (53)
  5. Biostatistics Service (51)
  6. Department of Pathology and Laboratory Medicine (43)

More Groups

People
  1. Dean Bajorin (80)
  2. Jonathan Rosenberg (70)
  3. Gopakumar Iyer (58)
  4. Irina Ostrovnaya (47)
  5. Samuel Funt (40)
  6. Hikmat Al-Ahmadie (38)

More People

Years
  1. 2025 (7)
  2. 2024 (7)
  3. 2023 (5)
  4. 2022 (10)
  5. 2021 (9)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (66)
  2. Clinical Genitourinary Cancer (7)
  3. JCO Precision Oncology (3)
  4. Cancer (2)
  5. Annals of Oncology (1)
  6. BJU International (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (70)
  2. Elsevier Inc. (7)
  3. Wiley Blackwell (4)
  4. American Association for Cancer Research (2)
  5. Nature Publishing Group (2)
  6. Oxford University Press (2)

More Publishers

Results (93)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identifying potential mechanisms of resistance to erdafitinib (erda) via longitudinal analysis of circulating tumor (ct)-DNA of patients (pts) with advanced/metastatic urothelial cancer
    Meeting Abstract

    Guercio, B. J.; Sarfaty, M.; Teo, M. Y.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Ratna, N.; Regazzi, A. M.; Chen, Z.; Lattanzi, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Association between molecular subtype membership or hypoxia-associated gene expression signatures and clinical outcomes in the CALGB 90601 (Alliance) phase 3 clinical trial of gemcitabine and cisplatin (GC) plus bevacizumab (B) or placebo (P)
    Meeting Abstract

    McConkey, D. J.; Choi, W.; Halabi, S.; Luo, B.; Al-Ahmadie, H. A.; Rosenberg, J. E.; Mountain, J.; Regazzi, A. M.; Fong, M.; Iyer, G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer
    Meeting Abstract

    Lattanzi, M.; Solovyov, A.; Lihm, J.; Quinlan, C.; Whiting, K.; Li, H.; Al-Ahmadie, H. A.; Teo, M. Y.; Aggen, D. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Association of DNA damage response (DDR) gene mutations (mts) and response to neoadjuvant cisplatin-based chemotherapy (chemo) in muscle-invasive bladder cancer (MIBC) patients (pts) enrolled onto SWOG S1314
    Meeting Abstract

    Iyer, G.; Tangen, C.; Sarfaty, M.; Regazzi, A. M.; Lee, I. L. C.; Choi, W.; Dinney, C. P. N.; Flaig, T. W.; Thompson, I. M.; McConkey, D. J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Association of DNA damage repair (DDR) mutations (mts) and clinical outcomes in CALGB 90601 (Alliance)
    Meeting Abstract

    Iyer, G.; Halabi, S.; Luo, B.; Rosenberg, J. E.; Choi, W.; Al-Ahmadie, H. A.; Mountain, J.; Regazzi, A. M.; Fong, M.; Mouw, K. W.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term outcomes of local and metastatic small cell carcinoma of the urinary bladder and genomic analysis of patients treated with neoadjuvant chemotherapy
    Journal Article

    Teo, M. Y.; Guercio, B. J.; Arora, A.; Hao, X.; Regazzi, A. M.; Donahue, T.; Herr, H. W.; Goh, A. C.; Cha, E. K.; Pietzak, E.; more...
    Clinical Genitourinary Cancer (2022)

    Fulltext@MSK | Save
  • Incidence and clinical outcomes of HER2-altered bladder cancer (BC) patients (pts)
    Meeting Abstract

    Lattanzi, M.; Niederhausern, A.; Zheng, J.; Bahadur, N.; Nichols, C.; Barton, L.; Gandhi, F.; Chan, K.; Insinga, A.; Philip, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma
    Journal Article

    Holm, J. S.; Funt, S. A.; Borch, A.; Munk, K. K.; Bjerregaard, A. M.; Reading, J. L.; Maher, C.; Regazzi, A.; Wong, P.; Al-Ahmadie, H.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with muscle-invasive bladder cancer: A multicenter, single-arm, phase II trial
    Journal Article

    Funt, S. A.; Lattanzi, M.; Whiting, K.; Al-Ahmadie, H.; Quinlan, C.; Teo, M. Y.; Lee, C. H.; Aggen, D.; Zimmerman, D.; McHugh, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • The cost of enfortumab vedotin wastage due to vial size — A real-world analysis
    Journal Article

    Sarfaty, M.; Moore, A.; Regazzi, A. M.; Mitchell, A. P.; Rosenberg, J. E.
    Cancers (2021)

    Fulltext@MSK | Save